CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative: The 5th edition of the WHO classification emphasizes that the presence of a CSF3R mutation at the time of diagnosis of aCML should be critically reviewed to exclude an alternative diagnosis of CNL [3].